Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks

OBJECTIVE: To identify factors predicting response (2‐hour headache pain freedom or most bothersome symptom freedom) to lasmiditan based on individual patient characteristics, migraine disease characteristics, and migraine attack characteristics. Further, efficacy specifically in difficult‐to‐treat...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Headache
Главные авторы: Tepper, Stewart J., Vasudeva, Raghavendra, Krege, John H., Rathmann, Suchitrita S., Doty, Erin, Vargas, Bert B., Magis, Delphine, Komori, Mika
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Research Submissions
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496706/
https://ncbi.nlm.nih.gov/pubmed/32634275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13897
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы